Clinical Trial

Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients

Study acronym: CHeMoON
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.
Trial Details
NCT Number NCT07483905
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Gynecologic Cancers
Enrollment 200 participants
Start Date 2026-03-12
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-19